Episode
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
- Published
- Jun 17, 2026
- Duration seconds
- 2969
- Processing state
not_requested- Canonical source
- https://oncologytoday.captivate.fm/episode/6009-gmo26-ubc
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/urothelial-bladder-cancer-fifth-annual-national-general-medical-oncology-summit/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/urothelial-bladder-cancer-fifth-annual-national-general-medical-oncology-summit.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Terence Friedlander and Dr Daniel P Petrylak, including the following topics: Introduction (0:00) Role of Immunotherapeutic Strategies in the Management of Nonmetastatic Urothelial Bladder Cancer (UBC); Emerging Utility of Circulating Tumor DNA Evaluation — Dr Friedlander (3:53) Other Novel Agents and Strategies for Nonmetastatic and Metastatic UBC — Dr Petrylak (26:41) CME information and select publications